Researchers have developed a soft artificial retina that helped blind mice respond to near-infrared light, a type of light ...
Belite Bio, Inc. (NASDAQ: BLTE), (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development company ...
Tech Xplore on MSN
This artificial retina doesn't just aim to restore sight—it opens a hidden channel of vision
The retina, the thin layer of tissue at the back of the eye, is made up of photoreceptor cells that convert visible light ...
Prevent Blindness, the nation's leading patient advocacy organization dedicated to protecting and preserving eye health, has ...
A rolling NDA has been initiated for tinlarebant in STGD1, potentially positioning the first disease-modifying systemic ...
Retinal diseases are among the fastest growing causes of blindness, having a profound impact on patients’ independence and ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
When preparing for cataract surgery in patients with retinal pathologies, ophthalmologists must be sure to set reasonable ...
Opus Genetics (Nasdaq: IRD) ('Opus Genetics” or the 'Company”), a clinical-stage biopharmaceutical company developing gene ...
A systematic review has found that pigmentary retinal changes may be an early or sole sign of Danon disease, a rare genetic disorder that can cause life-threatening cardiomyopathy. The analysis of 34 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results